Home/Pipeline/PANDA System

PANDA System

Diabetes (Insulin Delivery)

Pre-clinicalActive

Key Facts

Indication
Diabetes (Insulin Delivery)
Phase
Pre-clinical
Status
Active
Company

About SFC Fluidics

SFC Fluidics is a private medical device company leveraging proprietary microfluidic technology to create next-generation drug delivery systems. Its primary focus is the PANDA™ system, a patch pump for insulin delivery aimed at offering greater precision, safety, and convenience for diabetes patients. The company appears to be in a pre-revenue or early development stage, advancing its lead device while exploring broader applications of its platform. Leadership comprises a small, seasoned team with expertise in medical devices, microfluidics, and diabetes care.

View full company profile

Other Diabetes (Insulin Delivery) Drugs

DrugCompanyPhase
V-Go®MannKind CorpApproved